BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17093247)

  • 1. Return of chloroquine antimalarial efficacy in Malawi.
    Laufer MK; Thesing PC; Eddington ND; Masonga R; Dzinjalamala FK; Takala SL; Taylor TE; Plowe CV
    N Engl J Med; 2006 Nov; 355(19):1959-66. PubMed ID: 17093247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
    Kublin JG; Cortese JF; Njunju EM; Mukadam RA; Wirima JJ; Kazembe PN; Djimdé AA; Kouriba B; Taylor TE; Plowe CV
    J Infect Dis; 2003 Jun; 187(12):1870-5. PubMed ID: 12792863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
    Plowe CV; Kublin JG; Dzinjalamala FK; Kamwendo DS; Mukadam RA; Chimpeni P; Molyneux ME; Taylor TE
    BMJ; 2004 Mar; 328(7439):545. PubMed ID: 14757706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV; van der Wardt S; Talukder L; Chakma S; Brockman A; Nair S; Anderson TC
    Trop Med Int Health; 2004 Jun; 9(6):680-7. PubMed ID: 15189458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.
    Checchi F; Durand R; Balkan S; Vonhm BT; Kollie JZ; Biberson P; Baron E; Le Bras J; Guthmann JP
    Trans R Soc Trop Med Hyg; 2002; 96(6):664-9. PubMed ID: 12625147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
    Mayxay M; Newton PN; Khanthavong M; Tiengkham P; Phetsouvanh R; Phompida S; Brockman A; White NJ
    Clin Infect Dis; 2003 Oct; 37(8):1021-8. PubMed ID: 14523765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
    JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
    Ogunfowokan O; Dankyau M; Madaki AJ; Thacher TD
    Am J Trop Med Hyg; 2009 Feb; 80(2):199-201. PubMed ID: 19190213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan.
    Elamin SB; Malik el-FM; Ahmed el-DS; Elabadil EK; Mohamad TA
    East Mediterr Health J; 2007; 13(1):25-34. PubMed ID: 17546902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
    Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U
    Malar J; 2007 Dec; 6():170. PubMed ID: 18154655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
    Mwendera C; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Health Res Policy Syst; 2016 Jun; 14(1):41. PubMed ID: 27246503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
    MacArthur J; Stennies GM; Macheso A; Kolczak MS; Green MD; Ali D; Barat LM; Kazembe PN; Ruebush TK
    Am J Trop Med Hyg; 2001 Dec; 65(6):679-84. PubMed ID: 11791956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.